Share Name Share Symbol Market Type Share ISIN Share Description
Synthomer Plc LSE:SYNT London Ordinary Share GB0009887422 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.80 0.82% 469.60 469.60 470.20 477.40 465.00 477.40 93,410 15:02:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 1,644.2 20.3 0.7 670.9 1,995

Synthomer PLC Board Update

05/08/2021 7:01am

UK Regulatory (RNS & others)

Synthomer (LSE:SYNT)
Historical Stock Chart

From Jul 2021 to Oct 2021

Click Here for more Synthomer Charts.


RNS Number : 6238H

Synthomer PLC

05 August 2021

5 August 2021

Synthomer plc

Board update

Synthomer plc ('Synthomer' or 'the Company') today announces that Steve Bennett has informed the Board that he would like to stand down as Chief Financial Officer in due course. Steve has a twelve month notice period and has agreed to remain in his role until a successor is appointed to ensure a smooth transition. The Board has initiated a process to appoint Steve's replacement involving both internal and external candidates.

Steve has made a significant contribution to Synthomer since joining in April 2015. He has established a strong team and finance function, overseen several refinancings, significant investment and multiple acquisitions. This has contributed to Synthomer's strong growth during the period and the Company's solid financial platform today.

A further announcement will be made once a replacement has been appointed.

Caroline Johnstone, Chair of Synthomer, said:

"On behalf of the Board, I would like to thank Steve for the enormous contribution that he has made to Synthomer over the last 7 years. Together with the wider management team, he has helped to deliver significant growth and strategic change during his tenure. As a result of his initiatives, Synthomer has a highly capable finance function together with a strong financial position from which it can continue to pursue its growth strategy. Steve's successor will become an important member of the team to take Synthomer forward and I look forward to making a further announcement in due course to ensure a smooth transition."

Further information

Tim Hughes - President, Corporate 
 Development                        +44 1279 436211 
Charles Armitstead                  +44 7703 330 269 
Matt Denham                         +44 7825 735 596 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

August 05, 2021 02:01 ET (06:01 GMT)

1 Year Synthomer Chart

1 Year Synthomer Chart

1 Month Synthomer Chart

1 Month Synthomer Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20211022 14:18:55